The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy

Published:2014-01-28 Issue:4 Volume:36 Page:575-580
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Akgüllü Çağdaş,Saruhan Tevger,Eryilmaz Ufuk,Boyacıoğlu Murat,Onbaşılı Osman Alper,Meteoğlu İbrahim,Kum Cavit

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2014.880324

Reference33 articles.

1. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

2. Acute renal failure requiring dialysis after percutaneous coronary interventions

3. Pathophysiology of Contrast-Induced Nephropathy

4. Contrast Nephropathy After Coronary Angiography

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Antioxidant Properties and Cardiovascular, Antidiabetic, and Renal Effects of Trimetazidine Described in Research on Experimental Models;Current Reviews in Clinical and Experimental Pharmacology;2024-08-20

2. Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights;European Journal of Pharmacology;2021-12

3. Acute Kidney Injury in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Pathophysiologies, Risk Factors, and Preventive Measures;Cardiology;2021

4. The first spectrofluorimetric approach for accurate determination of trimetazidine in its dosage forms: Application to content uniformity testing;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2020-12

5. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency;Perfusion;2020-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3